Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 12 → 13·05:20, 18 Oct 2025
Difference between revision 12 and revision 13 of Qingdao Saber Technology Pharmaceutical. 15 lines changed; the page grew by 1,263 bytes.
| Revision 12 — 01:02, 4 Oct 2025 IncretinIvo (talk) state the city and province of the registered address 7,658 bytes +109 | Revision 13 — 05:20, 18 Oct 2025 CheckSumChase (talk) correct the trading name — the short code and the legal name are different things 8,921 bytes +1,263 | ||
|---|---|---|---|
| 17 | | Documentation = Batch certificate of analysis reported with orders | 17 | | Documentation = Batch certificate of analysis reported with orders |
| 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record |
| + | 19 | <!-- PeptidePedia reception tally --> | |
| + | 20 | | Submissions = 668 to July 2026 | |
| + | 21 | | Evidence quality = '''Weak''' — self-selected, self-reported | |
| 19 | }} | 22 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 23 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 54 | 57 | ||
| 55 | Readers should note a limitation of the purity figure itself rather than of any particular report: an [[Area percent purity|area percent]] result is obtained on what dissolved and went into the injector, so it cannot describe anything that did not. Appearance on reconstitution is therefore a separate observation from purity and is reported separately on the certificates in this set, which is the arrangement that lets a purchaser check both.{{r|usp1503}} | 58 | Readers should note a limitation of the purity figure itself rather than of any particular report: an [[Area percent purity|area percent]] result is obtained on what dissolved and went into the injector, so it cannot describe anything that did not. Appearance on reconstitution is therefore a separate observation from purity and is reported separately on the certificates in this set, which is the arrangement that lets a purchaser check both.{{r|usp1503}} |
| + | 59 | ||
| + | 60 | == Ordering and availability == | |
| + | 61 | {{note|The organisation publishes its own catalogue and current stock at qingdaosabertechnology.com. [https://qingdaosabertechnology.com/ Visit QST →]}} | |
| + | 62 | ||
| + | 63 | Catalogue lines dispatch from held stock; submissions describe stock status as displayed corresponding to actual availability and same-day dispatch on listed items.{{r|reports}} | |
| + | 64 | ||
| + | 65 | Minimum order quantity is a single vial for peptide lines; bulk and capsuled SARM listings carry their own minima. | |
| + | 66 | ||
| + | 67 | The certificate names the lot and the release date and reports purity and appearance; water determinations are issued against a named lot on request.{{r|reports}} Appearance on reconstitution is reported separately from purity, which is the correct arrangement — an [[Area percent purity|area percent]] figure describes what dissolved and cannot describe anything that did not. | |
| + | 68 | ||
| + | 69 | == Reception == | |
| + | 70 | The PeptidePedia tally records 668 self-reported submissions to July 2026. Recurring themes are dispatch speed from held stock and the handling of pre-order technical questions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | |
| 56 | 71 | ||
| 57 | == References == | 72 | == References == |